Successful Anti-SARS-CoV-2 Spike Protein Antibody Response to Vaccination in MAGT1 Deficiency

BACKGROUND: Novel messenger RNA vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV-2) have been vital in resolving the coronavirus disease-2019 (COVID-19) pandemic. Detection of neutralizing antibodies (NAbs) against the SARS-CoV-2 spike protein (S) confirms immunogenicity with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalil, Maaz, Rowane, Marija, Rajan, Jayanth, Hostoffer, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640323/
https://www.ncbi.nlm.nih.gov/pubmed/34868726
http://dx.doi.org/10.1177/21526567211056239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640323/
https://www.ncbi.nlm.nih.gov/pubmed/34868726
http://dx.doi.org/10.1177/21526567211056239

Ejemplares similares